UBR4
protein-codingubiquitin protein ligase E3 component n-recognin 4, the group of Armadillo like helical domain containing|Ubiquitin protein ligase E3 component n-recognins
Gene summary
The protein encoded by this gene is an E3 ubiquitin-protein ligase that interacts with the retinoblastoma-associated protein in the nucleus and with calcium-bound calmodulin in the cytoplasm. The encoded protein appears to be a cytoskeletal component in the cytoplasm and part of the chromatin scaffold in the nucleus. In addition, this protein is a target of the human papillomavirus type 16 E7 oncoprotein. [provided by RefSeq, Aug 2010]
- ZUBR1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~135.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0016227
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100309
Submitter: PMGRC
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to UBR4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020765.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 9 | 71 | 22 | 102 | ||
| missense | 3 | 549 | 16 | 7 | 575 | |
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 19 | 19 | ||||
| Total | 0 | 3 | 579 | 87 | 29 | 698 |
Highest pathogenic variant AF is 0.000019826395
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_065816.2 | 106 | MANE Select | |
| Ensembl | ENSP00000364403.3 | 106 | MANE Select | |
| Ensembl | ENSP00000364366.3 | 4 | Standard | |
| Ensembl | ENSP00000364372.1 | 20 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Viral carcinogenesis - Homo sapiens (human)
- Human papillomavirus infection - Homo sapiens (human)
- Neutrophil degranulation
- Innate Immune System
- Immune System
Biological Process
- ubiquitin-dependent protein catabolic process
- viral process
- protein ubiquitination
- neutrophil degranulation
Molecular Function
- ubiquitin-protein transferase activity
- protein binding
- calmodulin binding
- zinc ion binding
Cellular Component
- nucleoplasm
- centrosome
- cytosol
- plasma membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375254
- Coding exons
- 106
- Length
- 135771
- Individuals with no LoFs
- 125712
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 36
- Defined
- 125748
- p
- 0.000143
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.68 | 2000 | 2.85e+3 | 0.701 | 0.000166 | 33939 |
| Missense (PolyPhen) | 638 | 1172.3 | 0.54421 | 13707 | ||
| Synonymous | -0.452 | 1142 | 1.12e+3 | 1.02 | 0.0000656 | 10271 |
| Loss of Function | 13.9 | 16 | 255 | 0.0628 | 0.0000129 | 3054 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00012 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00018 | 0.00018 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase which is a component of the N-end rule pathway. Recognizes and binds to proteins bearing specific N-terminal residues that are destabilizing according to the N-end rule, leading to their ubiquitination and subsequent degradation. Together with clathrin, forms meshwork structures involved in membrane morphogenesis and cytoskeletal organization. Regulates integrin-mediated signaling. May play a role in activation of FAK in response to cell-matrix interactions. Mediates ubiquitination of ACLY, leading to its subsequent degradation. {ECO:0000269|PubMed:16214886, ECO:0000269|PubMed:23932781}.;
Recessive Scores
- pRec
- 0.127
Intolerance Scores
- LoFtool
- 0.297
- RVIS EVS
- -7.5
- RVIS percentile EVS
- 0.01
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.911
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |